NCT05175521Completed
Inhaled IAV vs Inhaled Eucalyptus for the Treatment of Nausea With Acute Migraine
Double Blind Randomized Control Trial of Inhaled Isopropyl Alcohol Vapors Versus Inhaled Eucalyptus Scent for the Treatment of Nausea Associated With Acute Migraine
Source: ClinicalTrials.gov · Last updated 17 Apr 2026
Brief summary (registry, in English)
The goal of this study is to compare the efficacy and adverse events of inhaled isopropyl alcohol vapor (IAV) versus placebo (inhaled eucalyptus scent (IES) (1:20 dilution in mineral oil) for treating nausea associated with acute migraine attacks.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 21 (actual)
- First submitted
- 19 Aug 2021
- Start date
- 11 Nov 2021
- Primary completion date
- 31 Dec 2025
- Lead sponsor
- HonorHealth Research Institute
- Diseases
- Migraine
- NCT number
- NCT05175521
What you commit to
- Study type: Interventional
- Participants enrolled: 21
- From 11 Nov 2021 to the primary completion date, 31 Dec 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Age
- Patients \<18 or \>65 years old
Other
- Patients without a diagnosis of acute migraine
Who the study is looking for
- Patients 18 to 65 years old with nausea associated migraines at least twice per month
Age in the registry: 18 years to 65 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| HonorHealth Bob Bové Neuroscience Institute Coordinator of this site? Confirm its status | Scottsdale | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.